Neurogene
Yahoo Finance • 22 days ago
Neurogene Reports Positive Long-Term Phase 1/2 Data For Rett Syndrome Gene Therapy
(RTTNews) - Neurogene Inc. (NGNE) on Monday reported positive long-term data from its Phase 1/2 study of NGN-401 in females with Rett syndrome, a rare neurological disorder that primarily affects girls. Across 10 participants, the therapy... Full story
Yahoo Finance • 5 months ago
Block upgraded, Duolingo downgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Morgan Stanley upgraded Block (XYZ) to... Full story
Yahoo Finance • 5 months ago
Neurogene Gets FDA Breakthrough Tag For NGN-401 In Rett Syndrome; Stock Up
(RTTNews) - Neurogene Inc. (NGNE) announced that the U.S. FDA has granted Breakthrough Therapy designation to NGN-401, its investigational gene therapy for Rett syndrome. Rett syndrome is a rare, devastating neurological disorder that pri... Full story
Yahoo Finance • last year
Short Report: Bears bite into Krispy Kreme after another weak earnings report
Welcome to this week’s installment of “The Short Interest Report” – The Fly’s weekly recap of short interest trends among some of the most widely followed high-short-float stocks. Using the data from our partner Ortex.com, which utilizes t... Full story